Risk factor
Very high price volatility
Profitability factor
Very weak growth
About
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It also develops DTcP vaccine for infants and DTcP Booster...
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E.
Target Price
The average target price of 6185.HK is 50 and suggests 30% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
Buy
Sell